FierceBiotech

Lophius Biosciences Announces Granting of Another Key Patent in the U.S.

Lophius Biosciences Announces Granting of Another Key Patent in the U.S. Regensburg, Germany, November 15, 2010 / b3c newswire / - Lophius Biosciences announced today that the USTPO has granted the ...
technologynetworks

Lophius Biosciences Joins NEU² Program

Bionamics GmbH and Lophius Biosciences GmbH have announced that Lophius Biosciences has joined the NEU² program with a project addressing the development of T-Track® MS as a novel blood-based ...
technologynetworks

Lophius Biosciences Closes Financing Round and Expands Management Board

With VRD GmbH and WIC GmbH two new investors will financially support the company alongside existing investors such as S-Refit, HighTech Gründerfonds (HTGF), Bayern Kapital and two Business Angels.
FierceBiotech

Lophius Biosciences GmbH Appoints Dr. Robert Phelps As Director Business Operations

Regensburg, Germany, December 4, 2013 / B3C newswire / – Lophius Biosciences GmbH, a privately held biotech company developing and marketing innovative T cell-based diagnostic systems for the early ...